ATE268332T1 - Verfahren zur herstellung von purin-derivaten - Google Patents
Verfahren zur herstellung von purin-derivatenInfo
- Publication number
- ATE268332T1 ATE268332T1 AT99917959T AT99917959T ATE268332T1 AT E268332 T1 ATE268332 T1 AT E268332T1 AT 99917959 T AT99917959 T AT 99917959T AT 99917959 T AT99917959 T AT 99917959T AT E268332 T1 ATE268332 T1 AT E268332T1
- Authority
- AT
- Austria
- Prior art keywords
- 12alkyl
- formula
- compound
- hydrogen
- purine derivatives
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
- 150000003212 purines Chemical class 0.000 title 1
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- -1 aryl carbonate Chemical compound 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 1
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 abstract 1
- 150000001335 aliphatic alkanes Chemical class 0.000 abstract 1
- 125000005116 aryl carbamoyl group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000005104 aryl silyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 229960004396 famciclovir Drugs 0.000 abstract 1
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 229960001179 penciclovir Drugs 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000006462 rearrangement reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9807116.0A GB9807116D0 (en) | 1998-04-02 | 1998-04-02 | Novel process |
| PCT/EP1999/002309 WO1999051604A2 (en) | 1998-04-02 | 1999-03-30 | Process for the production of purine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE268332T1 true ATE268332T1 (de) | 2004-06-15 |
Family
ID=10829765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99917959T ATE268332T1 (de) | 1998-04-02 | 1999-03-30 | Verfahren zur herstellung von purin-derivaten |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6437125B1 (https=) |
| EP (1) | EP1068210B1 (https=) |
| JP (1) | JP4459439B2 (https=) |
| KR (1) | KR100613812B1 (https=) |
| CN (1) | CN1125068C (https=) |
| AT (1) | ATE268332T1 (https=) |
| AU (1) | AU3605199A (https=) |
| BR (1) | BR9908959A (https=) |
| CA (1) | CA2323965A1 (https=) |
| DE (1) | DE69917765T2 (https=) |
| DK (1) | DK1068210T3 (https=) |
| ES (1) | ES2222702T3 (https=) |
| GB (1) | GB9807116D0 (https=) |
| IL (1) | IL138289A0 (https=) |
| PT (1) | PT1068210E (https=) |
| WO (1) | WO1999051604A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60202245T2 (de) | 2001-08-30 | 2005-09-01 | Ajinomoto Co., Inc. | Herstellungsmethode von Famciclovir und Herstellungs- bzw. Kristallisationsmethode eines entsprechenden Intermediates |
| AU2003268213A1 (en) * | 2002-08-26 | 2004-03-11 | Teva Pharmaceutical Industries Ltd. | Crystalline solid famciclovir forms i, ii, iii and preparation thereof |
| US7473780B2 (en) * | 2004-05-18 | 2009-01-06 | Teva Pharmeceutical Industries Ltd. | Drying process for preparing crystalline solid famciclovir |
| GB2426247A (en) * | 2005-05-20 | 2006-11-22 | Arrow Int Ltd | Methods of preparing purine derivatives such as famciclovir |
| CN110386935A (zh) * | 2018-04-20 | 2019-10-29 | 重庆常捷医药有限公司 | 一种泛昔洛韦中间体的合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3485225D1 (de) * | 1983-08-18 | 1991-12-05 | Beecham Group Plc | Antivirale guanin-derivate. |
| US5684153A (en) * | 1984-08-16 | 1997-11-04 | Beecham Group Plc | Process for the preparation of purine derivatives |
| EP0182024B1 (en) * | 1984-09-20 | 1991-04-03 | Beecham Group Plc | Purine derivatives and their pharmaceutical use |
| GB8817607D0 (en) | 1988-07-23 | 1988-09-01 | Beecham Group Plc | Novel process |
| US5688948A (en) * | 1991-09-18 | 1997-11-18 | Ajinomoto Co., Inc. | Process for isomerizing acyclic nucleosides and process for separating purine nucleosides |
| GB9407698D0 (en) * | 1994-04-19 | 1994-06-15 | Smithkline Beecham Plc | Pharmaceuticals |
| EP0827960A1 (en) * | 1996-09-10 | 1998-03-11 | Ajinomoto Co., Inc. | Process for producing purine derivatives |
-
1998
- 1998-04-02 GB GBGB9807116.0A patent/GB9807116D0/en not_active Ceased
-
1999
- 1999-03-30 AT AT99917959T patent/ATE268332T1/de not_active IP Right Cessation
- 1999-03-30 JP JP2000542325A patent/JP4459439B2/ja not_active Expired - Fee Related
- 1999-03-30 AU AU36051/99A patent/AU3605199A/en not_active Abandoned
- 1999-03-30 CN CN99804402A patent/CN1125068C/zh not_active Expired - Fee Related
- 1999-03-30 US US09/623,700 patent/US6437125B1/en not_active Expired - Lifetime
- 1999-03-30 CA CA002323965A patent/CA2323965A1/en not_active Abandoned
- 1999-03-30 WO PCT/EP1999/002309 patent/WO1999051604A2/en not_active Ceased
- 1999-03-30 KR KR1020007010706A patent/KR100613812B1/ko not_active Expired - Fee Related
- 1999-03-30 IL IL13828999A patent/IL138289A0/xx not_active IP Right Cessation
- 1999-03-30 DK DK99917959T patent/DK1068210T3/da active
- 1999-03-30 ES ES99917959T patent/ES2222702T3/es not_active Expired - Lifetime
- 1999-03-30 EP EP19990917959 patent/EP1068210B1/en not_active Expired - Lifetime
- 1999-03-30 DE DE69917765T patent/DE69917765T2/de not_active Expired - Fee Related
- 1999-03-30 BR BR9908959-9A patent/BR9908959A/pt not_active Application Discontinuation
- 1999-03-30 PT PT99917959T patent/PT1068210E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1068210E (pt) | 2004-10-29 |
| WO1999051604A3 (en) | 2000-02-17 |
| CN1125068C (zh) | 2003-10-22 |
| CN1294591A (zh) | 2001-05-09 |
| AU3605199A (en) | 1999-10-25 |
| JP2002510692A (ja) | 2002-04-09 |
| DE69917765D1 (de) | 2004-07-08 |
| HK1035896A1 (en) | 2001-12-14 |
| EP1068210A2 (en) | 2001-01-17 |
| DK1068210T3 (da) | 2004-09-20 |
| KR20010034701A (ko) | 2001-04-25 |
| KR100613812B1 (ko) | 2006-08-18 |
| ES2222702T3 (es) | 2005-02-01 |
| JP4459439B2 (ja) | 2010-04-28 |
| IL138289A0 (en) | 2001-10-31 |
| WO1999051604A2 (en) | 1999-10-14 |
| GB9807116D0 (en) | 1998-06-03 |
| CA2323965A1 (en) | 1999-10-14 |
| BR9908959A (pt) | 2000-12-05 |
| US6437125B1 (en) | 2002-08-20 |
| EP1068210B1 (en) | 2004-06-02 |
| DE69917765T2 (de) | 2005-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59108707D1 (de) | Verfahren zur Herstellung von Oxetanonen | |
| DE60009910D1 (de) | Verfahren zur herstellung von zsm-5 und zsm-11 | |
| DE3680800D1 (de) | Verfahren zur herstellung von (6r)-tetrahydro-l-biopterin. | |
| DE60025905D1 (de) | In vitro methode zur synchronisation von oozytenreifung | |
| ATE321773T1 (de) | Semisynthetisches verfahren zur herstellung von didemninanalogen | |
| ATE268332T1 (de) | Verfahren zur herstellung von purin-derivaten | |
| ATE344273T1 (de) | Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op) | |
| ATE359272T1 (de) | Verfahren zur herstellung von 3-hydroxy-n-1,6- | |
| DE60015563D1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
| ATE287879T1 (de) | Verfahren zur herstellung von isoflavonen | |
| ATE385232T1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
| DE50209620D1 (de) | Verfahren zur Herstellung von kristallinem Cholinascorbat | |
| ATE277919T1 (de) | Verfahren zur herstellung von baccatin iii- derivativen | |
| ATE299862T1 (de) | Verfahren zur herstellung von ketiminen | |
| ATE380171T1 (de) | Verfahren zur herstellung von terbinafine | |
| DE60107292D1 (de) | Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
| DE69926223D1 (de) | Verfahren zur herstellung von zwischenprodukten | |
| BR0113944A (pt) | Processo para a produção de compostos quirais | |
| ATE537160T1 (de) | Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat | |
| ATE466847T1 (de) | Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat | |
| DE59803194D1 (de) | Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen | |
| ATE301637T1 (de) | Verfahren zur herstellung von n-geschützten azetidin-2-carbonsäuren | |
| DE59304137D1 (de) | Verfahren zur herstellung von derivaten der bis(aminomethyl)phosphinsäure | |
| ATE299147T1 (de) | Verfahren zur herstellung von 3-amino-1,5- benzodiazepinderivaten | |
| ATE236135T1 (de) | Verfahren zur herstellung von 4,6- dichlorpyrimidin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1068210 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |